Europe

Nov 05, 2016
Leela Barham looks at the 18 recommendations of England’s Accelerated Access Review (AAR), which proposes how to speed up adoption of the best innovation in the NHS.
Oct 20, 2016
Leela Barham looks at NICE's latest proposals aimed at tackling the affordability challenge.
Oct 19, 2016
Cancer treatment is an increasing dilemma for health services as they try to balance patient care against budgetary constraints.
Oct 12, 2016
Pharmaceutical Executive
The potential collapse of the CETA agreement jeopardizes EU’s overall trade footing.
Oct 05, 2016
If Richard Bergström was not already planning his departure as Director General of EFPIA, his appearance at last week’s European Health Forum Gastein might have pushed him towards it.
Sep 07, 2016
Leela Barham reviews NHS England's proposals for the creation of Regional Medicines Optimization Committees.
Aug 15, 2016
Reflector outlines the obstacles ahead for Europe's revamped Innovative Medicines Initiative.
Aug 10, 2016
If managed access is to be a widely available option, it makes sense to re-assess just how much should be spent on it, writes Leela Barham.
Jul 29, 2016
A ‘new’ version of the English Cancer Drugs Fund (CDF) comes into force today. Leela Barham reports.
Jul 29, 2016
Paul Ranson examines how the UK biopharma must now adapt to a changing landscape.
native1_300x100
lorem ipsum